tositumomab (I 131 tositumomab)
General
General
General
Genetic Implications: 
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
to-si-too-mo-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.
Trade Name(s)
Ther. Class.
antineoplastics
Pharm. Class.
monoclonal antibodies
(radiolabled monoclonal antibodies)
There's more to see -- the rest of this topic is available only to subscribers.
TY - ELEC
T1 - tositumomab (I 131 tositumomab)
ID - 109615
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109615/all/tositumomab__I_131_tositumomab_
PB - F.A. Davis Company
ET - 20
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -
Try the app for free!
1. Download the Davis's Drug Guide app by Unbound Medicine
2. Select Try/Buy and follow instructions to begin your free 30-day trial
You can cancel anytime within the 30-day trial, or continue using Davis's Drug Guide to begin a 1-year subscription ($39.95)